BSPM - I'm predicting EPS of .20 vs. .03 due to increased popularity and affordability of their Hepatitis B drug, the only non-prescription drug in China approved for this condition .........
"which co,s reporting eps this coming week will announce the biggest upside surprises??? and why???"
Agree with joe's call on BSPM....but since that's taken, I'll pick the unloved/unwanted/disrespected CSOL, which is priced as thought it were heading into bankruptcy.
Any positive eps for CSOL will be a surprise for the market.